Trexquant Investment LP Reata Pharmaceuticals Inc Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$22.15 - $42.11 $357,611 - $679,865	16,145 New	16,145 $613,000
Q2 2021 Aug 12, 2021	SELL	$78.27 - $151.29 $161,236 - $311,657	-2,060 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$94.25 - $132.81 $1,036 - $1,460	11 Added 0.54%	2,060 $205,000
Q4 2020 Feb 11, 2021	BUY	$102.03 - $184.62 $209,059 - $378,286	2,049 New	2,049 $253,000
Q4 2019 Feb 12, 2020	SELL	$74.57 - $217.92 $243,620 - $711,944	-3,267 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$71.26 - $95.75 $232,806 - $312,815	3,267 New	3,267 $262,000
Q2 2019 Aug 09, 2019	SELL	$77.72 - $94.35 $519,325 - $630,446	-6,682 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$51.9 - $101.79 $242,943 - $476,478	-4,681 Reduced 41.2%	6,682 $571,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $76.44 $554,059 - $868,587	11,363 New	11,363 $637,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.